IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $36,919 | +8.6% | 105,483 | +15.2% | 0.00% | – |
Q3 2022 | $34,000 | -12.8% | 91,537 | +9.0% | 0.00% | – |
Q2 2022 | $39,000 | -39.1% | 83,941 | -33.9% | 0.00% | – |
Q1 2022 | $64,000 | -11.1% | 127,071 | +0.7% | 0.00% | – |
Q4 2021 | $72,000 | -45.9% | 126,179 | -3.2% | 0.00% | – |
Q3 2021 | $133,000 | -4.3% | 130,283 | +11.5% | 0.00% | – |
Q2 2021 | $139,000 | -9.7% | 116,877 | -1.3% | 0.00% | – |
Q1 2021 | $154,000 | +352.9% | 118,419 | +1188.0% | 0.00% | – |
Q4 2020 | $34,000 | +100.0% | 9,194 | +19.4% | 0.00% | – |
Q3 2020 | $17,000 | +70.0% | 7,701 | +43.6% | 0.00% | – |
Q2 2020 | $10,000 | +42.9% | 5,361 | -0.1% | 0.00% | – |
Q1 2020 | $7,000 | 0.0% | 5,365 | +43.5% | 0.00% | – |
Q4 2019 | $7,000 | -50.0% | 3,738 | -22.3% | 0.00% | – |
Q3 2019 | $14,000 | -54.8% | 4,811 | -58.0% | 0.00% | – |
Q2 2019 | $31,000 | +138.5% | 11,460 | +127.5% | 0.00% | – |
Q1 2019 | $13,000 | -85.1% | 5,038 | -83.9% | 0.00% | – |
Q4 2018 | $87,000 | -70.0% | 31,280 | -4.1% | 0.00% | – |
Q3 2018 | $290,000 | – | 32,608 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |